Pro Medicus Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Pro Medicus Limited - Depositary Receipt (Common Stock)
US ˙ OTCPK

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pro Medicus Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 58 59 64 68 74 81 87 93 100 106 115 125 134 142 152 162 173 185 199 213
Change (%) 1.98 7.56 7.03 9.36 8.56 7.83 7.26 6.72 6.29 8.91 8.18 6.89 6.45 6.82 6.38 7.15 6.67 7.69 7.14
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 0 0 0 0 1 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0
Change (%) 10.24 6.19 5.83 7.96 7.37 -9.07 -9.97 -3.98 -4.14 13.55 11.93 -10.48 -11.70 -15.00 -17.65 -3.32 -3.44 4.98 4.75
% of Revenue 0.68 0.74 0.73 0.72 0.71 0.70 0.59 0.50 0.45 0.40 0.42 0.44 0.36 0.30 0.24 0.19 0.17 0.15 0.15 0.15
Gross Operating Profit 58 59 63 68 74 80 87 93 99 106 115 124 133 142 151 161 173 184 198 213
Change (%) 1.93 7.57 7.04 9.37 8.57 7.95 7.36 6.77 6.34 8.89 8.16 6.97 6.52 6.88 6.44 7.17 6.69 7.70 7.15
% of Revenue 99.32 99.26 99.27 99.28 99.29 99.30 99.41 99.50 99.55 99.60 99.58 99.56 99.64 99.70 99.76 99.81 99.83 99.85 99.85 99.85
SG&A 17 17 17 17 18 19 20 22 23 25 28 31 34 36 37 39 40 42 45 47
Change (%) -3.45 0.25 0.25 7.59 7.06 5.86 5.54 8.56 7.88 11.51 10.32 7.94 7.36 3.74 3.61 4.37 4.19 5.90 5.57
% of Revenue 29.78 28.20 26.28 24.62 24.22 23.88 23.45 23.07 23.47 23.82 24.39 24.87 25.12 25.33 24.60 23.96 23.34 22.80 22.42 22.09
R&D
Change (%)
% of Revenue
OpEx 26 25 25 25 27 28 30 32 34 36 38 41 44 46 48 49 50 51 53 55
Change (%) -3.03 0.50 0.50 5.49 5.20 6.96 6.50 6.15 5.79 6.54 6.14 6.75 6.32 2.57 2.51 2.14 2.10 4.32 4.14
% of Revenue 44.79 42.59 39.79 37.36 36.04 34.93 34.64 34.40 34.21 34.05 33.31 32.68 32.64 32.60 31.30 30.16 28.75 27.52 26.66 25.91
Operating Income 32 34 38 43 48 53 57 61 66 70 77 84 90 96 104 113 123 134 146 158
Change (%) 6.05 12.80 11.35 11.67 10.45 8.30 7.66 7.02 6.56 10.13 9.20 6.97 6.51 8.87 8.15 9.31 8.51 8.97 8.23
% of Revenue 55.21 57.41 60.21 62.64 63.96 65.07 65.36 65.60 65.79 65.95 66.69 67.32 67.36 67.40 68.70 69.84 71.25 72.48 73.34 74.09
Interest Expense -0
Change (%)
% of Revenue -0.08
Net Income 24 25 28 31 34 38 41 44 48 51 56 61 65 70 76 83 91 98 107 115
Change (%) 3.13 12.79 11.34 11.56 10.37 8.50 7.83 7.33 6.83 9.51 8.69 7.47 6.95 9.39 8.58 9.36 8.56 8.61 7.93
% of Revenue 41.09 41.55 43.57 45.32 46.24 47.01 47.30 47.55 47.82 48.06 48.33 48.56 48.82 49.05 50.23 51.27 52.32 53.25 53.70 54.10

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista